Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Merlin ends drought for Boston tech firms after listing this week on the Nasdaq exchange

Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice

Russell 2000 enters correction territory, and the Dow, S&P 500, and Nasdaq are not far off

Here's the Smartest Way to Invest in the S&P 500 in March

Chattanooga-based NOVONIX has 180 days to fix NASDAQ $1 share price deficiency